Objective assessment of compliance with psoriasis treatment.
about
Topical treatments for chronic plaque psoriasisTopical treatments for chronic plaque psoriasisA Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory DiseasesAdolescent Scalp Psoriasis: Update on Topical Combination TherapyEthnopharmacological survey of medicinal plants used by patients with psoriasis in the West Bank of PalestineEffect of frailty syndrome on treatment compliance in older hypertensive patientsPsoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses.Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP).Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot studyEvidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists.Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.The challenge of patient adherence.Treatment Satisfaction Among Patients with Moderate-to-severe PsoriasisThe relation between different dimensions of alcohol consumption and burden of disease: an overviewQuality of life in patients with skin diseases in central Saudi Arabia.Calcipotriol/betamethasone dipropionate for the treatment of psoriasis.Adherence to treatment in patients with psoriasis.[Adherence to treatment in chronic dermatosis: about 200 cases]Use of clobetasol in lacquer for plaque psoriasis treatment.How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center.Psoriasis Patients' Knowledge about the Disease and Treatments.Psoriasis: consensus on topical therapies.Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study.Non-adherence to topical treatments for actinic keratosis.Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort studyA study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis.Chronic diseases and conditions related to alcohol use.Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN StudyEmerging Issues in Adult Female AcneEfficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.Topical treatment of psoriasis.Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.Maximizing patient adherence for optimal outcomes in psoriasis.Adherence in the treatment of psoriasis: a systematic review.Management of psoriasis and its comorbidities in primary care.Adherence to topical treatment in psoriasis: a systematic literature review.Adherence to medication in patients with psoriasis: a systematic literature review.The care triangle: determining the gaps in the management of atopic dermatitis.Alcohol and psoriasis: sobering thoughts.Non-adherence and measures to improve adherence in the topical treatment of psoriasis.
P2860
Q24198258-6848966C-6E50-43D4-959C-20E9B09C8EB1Q24241239-BCFEB2F5-6E07-4BE6-B83B-BA879BD72941Q26778585-A0383213-920E-4702-A843-FE35DFD71A4FQ26800230-20983419-3976-4959-8840-2DBD6013BC49Q33458860-EF98FC54-2356-4874-9D78-7CFFED9F13E1Q33713805-14B4CB0F-723F-40FA-9E7E-8D3F941E9A91Q33767803-8AB02567-7863-4265-9CCC-35695C6EE0F1Q34071609-7ABE0E71-7768-4E79-9241-D9D7D20C894AQ34159532-88D0B77B-23C7-41BB-9CEA-A017352AA8DCQ34237346-C970955E-0CEC-46ED-B0CD-C2404B22B3DAQ35039946-2941AFF1-C6AC-4D53-BD95-72AE3B3E77EDQ35166717-9685E7AE-15AF-4721-8DFE-D2D188DDFC6AQ35686609-5ADE079A-9728-4CBF-92BB-2380D0DEC88EQ35835324-C726B7CF-2A90-4C7D-95A0-7E3FF51C8144Q36136432-99C38A16-57C2-450F-B81F-247AEB62F4A2Q36428510-EF8A9BBB-2044-4361-8FA3-CC4176C18B83Q36461970-CDC9811C-79AF-41A0-A756-F365140B0144Q36522267-F9D4242B-B40F-4C8C-AC1E-40801373ED7CQ36663256-553E5BC8-0AAF-4CF6-8BD7-B5A0ECD11796Q36921945-0C683773-34B6-4020-9A6E-246E1D772442Q36999519-419330E1-A4B9-4F29-9818-61CBE4C5E4BAQ37032806-67D4DE81-4455-4873-8DDB-22E8A6224EEFQ37095225-3F0338EC-227F-43A5-94A9-F78C61669C64Q37412640-356288E1-96B7-411C-8550-30CCCBB42B9CQ37449514-9A06EBFC-C4C9-41FD-B22F-2B28BD568253Q37466717-4E326BE3-9D97-43E4-ABE3-13EB59ACD33EQ37537406-D2429D66-643E-4F90-9489-C091A7EDDD65Q37562617-C2C63B9F-8B61-4111-BE93-6B6E60684E1FQ37634315-71E3C2A7-6AA6-4C8B-AF06-5628EC03CDCDQ37743492-5747ECD1-5488-48ED-9878-AA87C1E23D7BQ37766897-A0F4892C-5580-4D83-A177-4D7D47DEEFE3Q37866759-B17E546B-B440-4420-9840-7832DBDD91AFQ37867174-F8049988-4990-43A5-93D6-EBF6DDBC7DF6Q37901280-50ECA2FC-3DC6-4E54-9FBB-F3E08705CFF8Q37954016-375E4BC1-EAA4-4650-AA26-31B25ECE5483Q38003487-899EA184-0492-41BE-BA7A-9CF4745A834EQ38042075-BF2C3C3F-3735-454F-A2D6-C45319A3159CQ38118407-AE77C7B6-0342-4227-BB5A-6EA4D5833C42Q38164129-4FF0A165-AD96-48CF-B368-0FEFBE52FD33Q38200706-95C4C0C7-91B1-468C-8504-E1ADAAABBAEB
P2860
Objective assessment of compliance with psoriasis treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Objective assessment of compliance with psoriasis treatment.
@en
Objective assessment of compliance with psoriasis treatment.
@nl
type
label
Objective assessment of compliance with psoriasis treatment.
@en
Objective assessment of compliance with psoriasis treatment.
@nl
prefLabel
Objective assessment of compliance with psoriasis treatment.
@en
Objective assessment of compliance with psoriasis treatment.
@nl
P1433
P1476
Objective assessment of compliance with psoriasis treatment.
@en
P2093
Mark Jeremy David Goodfield
Sameh Said Zaghloul
P304
P356
10.1001/ARCHDERM.140.4.408
P577
2004-04-01T00:00:00Z